CLRB · Cellectar Biosciences, Inc.
$2.59
+0.03 (+1.17%)
At close · Aug 18
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$24.58M
Shares
9.45M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-18 | The Platform Behind the Pipeline: Unlocking the Full Potential of Cellectar's Phospholipid Drug Conjugate™ Technology | Event |
| 2026-08-13 | Second Quarter 2026 Earnings Call | Earnings call |
| 2026-07-07 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-05-14 | First Quarter 2026 Earnings Call | Earnings call |
| 2026-03-04 | Fourth Quarter and Full Year 2025 Earnings Call | Earnings call |
| 2026-01-13 | 44th Annual JP Morgan Healthcare Conference | Conference |
Key facts
CIK
1279704
CUSIP
15117F880
13F (30d)
34 filings
28 filers
Visit website
Investor relations